HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Beauty In The Metaverse: Top Companies Move To Fence Off IP With Eyes On Seminal Court Cases

Executive Summary

The world’s biggest cosmetics companies are filing trademark applications to compete and protect their brands in the metaverse, an online mirror of the real world that is still largely imaginary but which Facebook, now Meta Platforms, is committed to building in its next chapter.

You may also be interested in...



Metaverse May Be ‘Blurry,’ But Expectations For Advertising To Children Are Not – CARU

The Children’s Advertising Review Unit of the BBB National Programs Inc. tells marketers its guidelines apply to ads in the metaverse, and the watchdog will ‘strictly enforce’ in the space.

Dinosaur Among The Unicorns: L'Oreal Talks Beauty Tech Innovation At VivaTech 2022

L’Oreal Group’s CEO referred VivaTech 2022 attendees to Yves Saint Laurent Beauty Scent-Sation, an electroencephalography-based headset that reads consumers’ emotional responses to different scent families, as an example of the firm’s beauty tech innovation that is personalizing the consumer experience, matching consumers with products, and distinguishing L’Oreal as a … err … “T-unicorn.”

E.l.f. Beauty Sales Jump 50% With Makeup Rebound, Online Gaming Push

Gen Z-focused E.l.f. Beauty Inc. booked 50% net sales growth in its fiscal 2022 first quarter with continued improvisation across social media platforms where mainstream players still hesitate to venture.

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS152340

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel